Ceftazidime/avibactam

DRUG2 trials

Sponsors

University of Southern California, Michigan State University

Conditions

Cystic FibrosisPharmacokinetics of Avycaz in ICU Patients

Phase 1

A Study of Avycaz (Ceftazidime/Avibactam) Pharmacokinetics/Pharmacodynamics (PK/PD) in Critically Ill Patients

CompletedNCT02822950

Michigan State UniversityPharmacokinetics of Avycaz in ICU Patients

Start: 2017-01-31End: 2017-12-31Updated: 2019-03-06

Phase 4

Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis

CompletedNCT02504827

University of Southern CaliforniaCystic Fibrosis

Start: 2015-09-30End: 2016-10-31Updated: 2018-11-27

Related Papers

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Determine Optimal Dosing of Ceftazidime-Avibactam for the Treatment of Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis

Antimicrobial Agents and Chemotherapy2017-08-0847 citations